We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Consensus Estimate for earnings in the to-be-reported quarter stands at 19 cents, indicating a 13.6% decline from the year-ago reported quarter. The consensus estimate for revenues stands at $424.8 million, implying 4.8% year-over-year growth. There has been no change in analyst estimates or revisions lately.
Image Source: Zacks Investment Research
The company has an impressive earnings surprise history. Earnings surpassed the Zacks Consensus Estimate in all the trailing four quarters, with an earnings surprise of 38.8%, on average.
Image Source: Zacks Investment Research
Lesser Chance of Q4 Earnings Beat for PATH
Our proven model doesn’t conclusively predict an earnings beat for PATH this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter.
The Zacks Consensus Estimate for subscription services revenues is pegged at $209 million, indicating 18.8% year-over-year growth. The consensus estimate for professional services and other revenues is pegged at $10 million, implying 11% year-over-year growth. The consensus mark for license revenues is pegged at $137.3 million, implying a 6.4% year-over-year decline.
PATH Stock Has Been Consolidating
The stock has been consolidating for more than nine months, showing hardly any movement compared to the industry's 47% growth and the Zacks S&P 500 Composite’s 10.4% rise. PATH’s performance outperforms Varonis Systems (VRNS - Free Report) , which has declined 7.8%, but underperforms Trend Micro Incorporated (TMICY - Free Report) , which has rallied 48% in the same time frame.
Image Source: Zacks Investment Research
Pre-Earnings Investment Considerations for PATH
PATH approaches its earnings release amid a consolidating stock performance and trailing industry growth. While its subscription segment remains a key strength, the company faces near-term challenges, including earnings pressure and uncertain market sentiment.
Despite its strong track record of surpassing expectations, the absence of favorable indicators for an earnings beat suggests limited short-term catalysts. Investors may find it prudent to adopt a wait-and-see approach, as PATH’s long-term potential remains intact but lacks immediate momentum.
With the broader market uncertainty and PATH’s stock yet to break out of consolidation, holding steady could be a cautious yet strategic move. A clearer direction post-earnings may offer a better entry or exit point.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Pre-Q4 Earnings: Should PATH Stock be in Your Portfolio?
UiPath Inc. (PATH - Free Report) will report its fourth-quarter fiscal 2025 results on March 12, after the bell.
See Zacks Earnings Calendar to stay ahead of market-making news.
The Zacks Consensus Estimate for earnings in the to-be-reported quarter stands at 19 cents, indicating a 13.6% decline from the year-ago reported quarter. The consensus estimate for revenues stands at $424.8 million, implying 4.8% year-over-year growth. There has been no change in analyst estimates or revisions lately.
The company has an impressive earnings surprise history. Earnings surpassed the Zacks Consensus Estimate in all the trailing four quarters, with an earnings surprise of 38.8%, on average.
Lesser Chance of Q4 Earnings Beat for PATH
Our proven model doesn’t conclusively predict an earnings beat for PATH this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter.
PATH has an Earnings ESP of 0.00% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Subscription Should be PATH’s Key Driver in Q4
The Zacks Consensus Estimate for subscription services revenues is pegged at $209 million, indicating 18.8% year-over-year growth. The consensus estimate for professional services and other revenues is pegged at $10 million, implying 11% year-over-year growth. The consensus mark for license revenues is pegged at $137.3 million, implying a 6.4% year-over-year decline.
PATH Stock Has Been Consolidating
The stock has been consolidating for more than nine months, showing hardly any movement compared to the industry's 47% growth and the Zacks S&P 500 Composite’s 10.4% rise. PATH’s performance outperforms Varonis Systems (VRNS - Free Report) , which has declined 7.8%, but underperforms Trend Micro Incorporated (TMICY - Free Report) , which has rallied 48% in the same time frame.
Pre-Earnings Investment Considerations for PATH
PATH approaches its earnings release amid a consolidating stock performance and trailing industry growth. While its subscription segment remains a key strength, the company faces near-term challenges, including earnings pressure and uncertain market sentiment.
Despite its strong track record of surpassing expectations, the absence of favorable indicators for an earnings beat suggests limited short-term catalysts. Investors may find it prudent to adopt a wait-and-see approach, as PATH’s long-term potential remains intact but lacks immediate momentum.
With the broader market uncertainty and PATH’s stock yet to break out of consolidation, holding steady could be a cautious yet strategic move. A clearer direction post-earnings may offer a better entry or exit point.